Background
==========

Haemangioblastoma is a slowly growing, highly vascular benign tumor, corresponding to WHO grade I. It typically arises within the central nervous system (CNS), but may occasionally originate in unusual sites such as peripheral nerve, bone, soft tissue, skin, liver, lung and pancreas \[[@B1]-[@B3]\], and maybe associated with von Hippel-Lindau (VHL) disease.

The kidney is another rare site for the development of sporadic haemangioblastoma growth, and only four cases have been reported in the English-language literature so far \[[@B4]-[@B6]\]. The accurate diagnosis is often challenging when the tumor develops in this region. We described herein the fifth case of this rare tumor, which notably demonstrated a rhabdoid phenotype as well as unexpected CD10 staining. In addition, the shared characteristics of renal haemangioblastomas (RHB) and their differential considerations were also discussed in detail.

Case presentation
-----------------

A 61-year-old man was admitted to our hospital for a solid mass found in the right kidney during a routine checkup. Computed tomography showed that the mass was located in the superior pole. No remarkable symptoms such as flank pain or urinary irritation were reported by the patient. He also had no familial history or clinical evidences of VHL disease. Radical nephrectomy was carried out, showing a 5.3 × 5.0 × 5.0 cm mass. It was grey to yellowish in color and well-demarcated from the surrounding renal parenchyma. The patient had an uneventful postoperative recovery and was well at 12 months follow-up.

Histopathological and Immunohistochemical findings
--------------------------------------------------

Microscopically, the specimen consisted of nests of polygonal tumor cells and a prominent capillary network. Focal areas of necrosis were present. The stroma showed extensive fibrosis and hyalinization, which amounted to approximately one third of the lesion (Figure [1A, B](#F1){ref-type="fig"}).

![**Histopathological findings of the renal hemangioblastoma**. (**A**) Stromal hyalinization was prominent among the neoplasm and foci of necrosis were observed inside the tumor (left field) (H&E staining, with original magnification ×40). (**B**) The tumor cells were arranged in nests and traversed by a vascular network (H&E staining, with original magnification ×100). (**C**) Lipid vesicles were abundant in some tumor cells (H&E staining, with original magnification ×400). (**D**) The tumor cells had enlarged eosinophilic cytoplasm and eccentrically-displaced nuclei, exhibiting a rhabdoid phenotype (H&E staining, with original magnification ×200). (**E**) Pseudo-nuclear invaginations were another distinctive feature of tumor cells (H&E staining, with original magnification ×400). (**F**) The sclerotic stroma dispersed tumor cells into isolated small nests (H&E staining, with original magnification ×100). The vessels in between were usually dilated and some of them resembled the changes of papillary endothelial hyperplasia (inserted panel, H&E staining, with original magnification ×400).](1746-1596-7-39-1){#F1}

The majority of the neoplastic cells were enlarged with marked eosinophilic cytoplasm that sometimes contained sharply delineated lipid vacuoles. A few cells showed highly vacuolated and clear cytoplasm. The nuclei were generally eccentric, mildly to moderately pleomorphic with coarse granular chromatin, resembling the rhabdoid cells (Figure [1C, D](#F1){ref-type="fig"}). The nucleoli were inconspicuous. However, there were many prominent intranuclear cytoplasmic pseudoinclusions (Figure [1E](#F1){ref-type="fig"}). Mitotic figures were detectable but were exceedingly rare.

The tumor cells displayed an alternation of cellular and reticular growth patterns. In the former, zellballen-like cellular clusters of neoplastic cells enclosed discrete and sparse vessels. In the latter, trabeculae of neoplastic cells were traversed by abundant slit-like sinusoids. In regions with extensive stromal fibrosis, the tumor cells were dispersed and progressively replaced by hyalinized collagen. The coupled vessels were remained and were frequently dilated (Figure [1F](#F1){ref-type="fig"}).

Reticular fibers enclosed both tumor cells and vasculature in the areas of reticular growth pattern, but barely surrounded the vessel walls in the regions of cellular growth pattern (Figure [2](#F2){ref-type="fig"}). PAS staining for glycogen was negative in tumor cells.

![**Reticulins were found around individual tumor cells as well as the vascular channels (reticulin growth pattern, right field)**. Alternatively, only the vascular channels were delineated (cellular growth pattern, left field) (Reticular staining, with original magnification ×200).](1746-1596-7-39-2){#F2}

The neoplastic cells displayed diffuse immunoreactivity for a-inhibin, NSE, S100, vimentin and EGFR. Focal membranous staining was noted for CD10 and EMA. The Ki-67 index was approximately 1%. CD34 outlined the vascular structures (Figure [3](#F3){ref-type="fig"}). There was no positive staining for AE1/AE3, CK8/18, CK19, gp200, calretinin, HMB-45, Melan-A, chromogranin, Desmin, Actin, Myoglobin and CD68 (Table [1](#T1){ref-type="table"}).

![**Immunoprofiles of the renal hemangioblastoma**. The neoplastic cells showed diffuse positive staining for S100 (**A**), NSE (**B**) and a-inhibin (**C**) (with original magnification ×400). Some tumor cells were immunoreactive with CD10 (with original magnification ×200) and bright membrance staining were observed (inserted panel, with original magnification ×400) (**D**). CD34 underlined the rich vascular channels (**E**) (with original magnification ×200). The Ki-67 index was around 1% (**F**) (with original magnification ×100).](1746-1596-7-39-3){#F3}

###### 

Panel of immunohistochemical stains

  Immunohistochemical stains                Clone                        Sources      Dilution   Results
  ----------------------------------------- ---------------------------- ------------ ---------- --------------
  Pan cytokeratin                           AE1/AE3                      Neomarkers   1:100      Neg.
  Keratin 8/18                              5D3                          Neomarkers   1:200      Neg.
  Keratin 19                                RCK108                       Neomarkers   1:200      Neg.
  Renal Cell Carcinoma Marker(gp200)        PN-15                        Neomarkers   1:100      Neg.
  Neuron-specific enolase (NSE)             NSE-P1                       Neomarkers   1:1500     Pos.
  Epithelial membrane antigen (EMA)         E29                          Neomarkers   1:500      Pos. (focal)
  CD10                                      56 C6                        Neomarkers   1:50       Pos. (focal)
  Ki-67                                     SP6                          Neomarkers   1:500      Pos. (1%)
  Vimentin                                  SP20                         Neomarkers   1:300      Pos.
  S100 protein                              Polyclonal antiserum         Dako         1:6000     Pos.
  a-inhibin                                 R1                           Dako         1:1250     Pos.
  Epidermal growth factor receptor (EGFR)   EP38Y                        Neomarkers   1:100      Pos.
  calretinin                                SP13                         Neomarkers   1:100      Neg.
  Melanoma Marker                           HMB45                        Neomarkers   1:50       Neg.
  Melan-A                                   A103                         Neomarkers   1:100      Neg.
  Chromogranin A                            SP12                         Neomarkers   1:200      Neg.
  Desmin                                    Rabbit Polyclonal Antibody   Neomarkers   1:200      Neg.
  Actin                                     HHF35                        Neomarkers   1:100      Neg.
  Myoglobin                                 Rabbit Polyclonal Antibody   Neomarkers   1:800      Neg.
  CD68                                      PG-M1                        Neomarkers   1:100      Neg.
  CD34                                      QBEnd/10                     Neomarkers   1:80       Neg.

Discussion
==========

Renal haemangioblastoma (RHB) is extremely uncommon since only four cases were definitely reported previously (Table [2](#T2){ref-type="table"}). Our case was specifically in line with the diagnostic clues of RHB suggested by Ip et al \[[@B5]\] and Verine et al \[[@B6]\]. Those characteristics included circumscribed borders, paucity of mitotic figures, fine vacuoles in some tumor cells indicating presence of intracytoplasmic lipids, and a rich capillary network. The immunoprofiles (S100 +, NSE+, a-inhibin + and AE1/AE3-) also conformed to those of haemangioblastomas. However, the majority of the tumor cells in our case showed rhabdoid features, which may be easily mistaken for other rhabdoid tumors that are known to occur in the kidney.

###### 

Clinicopathological characteristics of the reported sporadic hemangioblastomas in the kidney

  Case              Age(y)/Sex   Gross features                                                Histological features                                      Immunohistochemical staining                                                                           Treatment/Follow-up(y)                                                                                
  ----------------- ------------ ------------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------------------------------------------------ ------------------------ --------- ----------------------------- ------------------------------------ ----------
  1(ref.4)          71/female    Solid with scattered cystic spaces; located in right kidney   Amphophilic to clear                                       Round with delicate chromatin; lack of mitoses                                                         Absent                   Present   a-inhibin                     Vimentin, S100, SMA, MSA, calponin   NP/AW/9
  2(ref.5)          58/male      Solid with a cystic cavity; located in right kidney           Eosinophilic                                               Mildly to highly pleomorphic; lack of mitoses                                                          Absent                   Present   a-inhibin, S100, NSE, GLUT1                                        NP/AW/2
  3(ref.5)          55/female    Solid; located in right kidney                                Eosinophilic; variable-sized hyaline globules were found   Mildly to highly pleomorphic; very sparse mitoses                                                      Present                  Present   a-inhibin, S100, NSE, GLUT1                                        NP/AW/4
  4(ref.6)          64/male      Solid; located in left kidney                                 Weakly eosinophilic                                        Enlarged and slightly atypical; lack of mitoses                                                        Absent                   Present   S100, NSE, Vimentin           EMA, a-inhibin                       pNP/AW/4
  5(present case)   61/male      Solid; located in right kidney                                Eosinophilic; exhibiting a rhabdoid phenotype              Mildly to highly pleomorphic; intranuclear cytoplasmic pseudoinclusions were present; sparse mitoses   Present                  Present   a-inhibin, S100, NSE, EGFR    CD10, EMA                            NP/AW/1

NP, nephrectomy; pNP, partial nephrectomy; AW, alive and well

In our opinion, the first differential consideration is the malignant rhabdoid tumors (MRTs). Although most of MRTs afflict young children, there still are sporadic cases affecting adults \[[@B7],[@B8]\]. Several features seen in our case do not support the diagnosis of MRTs: (i) MRTs generally show vesicular chromatin, prominent nucleoli and hyaline intracytoplasmic inclusion \[[@B8]\]. The neoplastic cells in our case demonstrated dark-stained and coarse granular chromatin, and lack the discernable nucleoli as well as cytoplasmic inclusions. (ii) MRTs are devoid of the cytoplasmic lipid droplets and arborizing stromal vasculature, characterized by haemangioblastomas. (iii) Immunohistochemically, MRTs occasionally are focally positive for S100 and NSE \[[@B9]\], but a-inhibin staining was not shown. The features are different from the extensive expression of S100, NSE and a-inhibin seen in RHB. (IV) MRTs are a highly invasive and lethal neoplasm with a proliferation index of Ki-67 around 95% \[[@B8]\]. In contrast, the extremely low Ki-67 index and rare mitosis indicate an indolent behavior of our case.

Another necessary differential consideration is renal cell carcinomas with rhabdoid features (RCCR), which have been previously described \[[@B10],[@B11]\]. RCCR are predominantly composed of large polygonal cells with eccentric nuclei and eosinophilic cytoplasm. Of the 23 cases analyzed by Gökden et al. \[[@B10]\], RCCR showed a diffuse NSE staining (79% of cases) and focal positive staining for EMA (47% of cases) and S-100 (37% of cases), whereas cytokeratin expression was decreased (56% of cases). Obviously, there are many morphologic and immunophenotypic features that markedly overlap with our present case. Nevertheless, compared with RCCR, the tumor cells of our case did not display the vesicular nuclei and prominent nucleoli. Furthermore, RHB is characterized by abundant vascular networks, which are strikingly reduced in RCCR \[[@B11]\]. In addition, RHB demonstrates negative PAS staining for glycogen, whereas this staining is positive in RCCR \[[@B11]\]. The low Ki-67 index in our case is also not compatible with the high proliferative index in RCCR \[[@B12]\].

Other neoplasms with rhabdoid features possibly that need to be considered before making the diagnosis of RHB include epithelioid angiomyolipoma (HMB-45^+^and Melan-A^+^), malignant melanoma with rhabdoid features (HMB-45^+^and Melan-A^+^) \[[@B13]\], paraganglioma (synaptophysin^+^, chromogranin^+^and a-inhibin^-^), epithelioid leiomyosarcoma with rhabdoid features (SMA^+^, desmin^+^and S100^-^) \[[@B14]\], and epithelioid malignant peripheral nerve sheath tumor (a-inhibin^-^) \[[@B15]\].

Interestingly, focal CD10 positivity was observed in some tumor cells of our present case. In the normal kidney, CD10 stains glomerular cells and proximal convoluted tubules, and participates in the regulation of water and sodium metabolism \[[@B16]\]. Thus, CD10 expression in RHB seemingly substantiates the earlier hypothesis that haemangioblastomas are derived from pluripotent mesenchymal cells, and partially acquire some site-specific markers of their parental organs during pathogenesis \[[@B4]\]. Many studies have suggested CD10 is a powerful marker in the differentiation between renal cell carcinoma and haemangioblastoma since it usually demonstrates positive staining in renal cell carcinoma while is steadily negative in haemangioblastoma \[[@B17]\]. Our result indicates that caution should be taken on evaluating the differential efficacy of this reagent. Noticeably, Verine et al. \[[@B6]\] reported a negative result of CD10 staining in their case of RHB. The reasons for the discrepancy remain unknown, and probably either reflect the intrinsic disparities of expressional profiles between the two specimens, or may be just caused by different antibodies used.

Some investigators have suggested that RHB would not be as rare if it had got wider recognition as a primary renal tumor \[[@B5],[@B6]\]. So it is undoubtedly necessary to be aware of the clinicopathologic characteristics of RHB. From the available data, RHB commonly occurs in the elderly people (range 55 to 71 years) and there is no sex predilection. The right kidney seems more prone to be affected and the superior pole is likely the preferential site of mass development. Grossly, these tumors displayed a solid cut surface, though cystic changes were occasionally observed. Architecturally, the lesions were consistently composed of cellular and paucicellular regions. In the cellular areas, the tumor could be subclassified as reticular and cellular variants analogous to cerebellar haemangioblastoma \[[@B18]\]. In the paucicellular zones, stromal fibrosis was prominent. Cytologically, the neoplastic cells in RHB generally contained mild to remarkably eosinophilic cytoplasm and frequently outnumbered the clear cells with rich lipid droplets. The nuclei were often enlarged and hyperchromatic, and frequently displayed some pleomorphism. In addition to the positivity for S100, a-inhibin and NSE, focal expression of EMA, SMA, MSA and calponin were also noted \[[@B5]\]. Nevertheless, Cytokeratins, HMB-45, Melan-A, chromogranin, calretinin, and Myoglobin were characteristically negative.

Compared with cerebellar haemangioblastoma (CHB), RHB manifest with some different features. For instance, RHB incidence peaks in the sixth decade compared to the fourth decade of CHB \[[@B19]\]. RHB usually presents as a solid mass, whereas 65 percent of CHB manifest as a cystic mass \[[@B20]\]. The acidophilic cytoplasm and pleomorphic nuclei that are frequently present in renal tumors are usually not seen in CHB. Stromal hyalinization in RHB is also more prominent than that in CHB. However, the immunophenotype and benign behaviors of RHB reflect the essential consistency with CHB.

Conclusions
===========

We have presented another case of RHB, which demonstrates distinctive rhabdoid features and focal CD10 expression. The tumor cells of RHB generally show abundant acidophilic cytoplasm and pleomorphic nuclei, whereas the characteristic stromal cells with finely-vacuolated lipid droplets are not usually prominent. Diffuse expression of S100, a-inhibin and NSE are very helpful to narrow down the differential diagnoses. The unexpected positive staining of CD10 in RHB should be particularly concerned. RHB have excellent prognosis, and tumor necrosis and nuclear pleomorphism do not seem to affect the prognosis. Most importantly, RHB should be included in the differential diagnosis of primary renal tumors.
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